Free Trial

MarketBeat Instant News Alerts

Insulet logo with Medical background

Insulet (NASDAQ:PODD) Now Covered by Analysts at Truist Financial

MarketBeat

Truist Financial started coverage on shares of Insulet in a research report on Monday. They set a "buy" rating and a $365.00 price target on the stock.

NASDAQ:PODD
Read Insulet (NASDAQ:PODD) Now Covered by Analysts at Truist Financial
Tandem Diabetes Care logo with Medical background

Truist Financial Begins Coverage on Tandem Diabetes Care (NASDAQ:TNDM)

MarketBeat

Truist Financial started coverage on shares of Tandem Diabetes Care in a research note on Monday. They issued a "hold" rating and a $24.00 price objective for the company.

NASDAQ:TNDM
Read Truist Financial Begins Coverage on Tandem Diabetes Care (NASDAQ:TNDM)
ZenaTech logo with Business Services background

Maxim Group Initiates Coverage on ZenaTech (NASDAQ:ZENA)

MarketBeat

Maxim Group assumed coverage on ZenaTech in a research report on Monday. They issued a "buy" rating and a $9.00 target price on the stock.

NASDAQ:ZENA
Read Maxim Group Initiates Coverage on ZenaTech (NASDAQ:ZENA)
British American Tobacco logo with Consumer Defensive background

British American Tobacco (LON:BATS) Hits New 12-Month High - What's Next?

MarketBeat

British American Tobacco (LON:BATS) Sets New 1-Year High - Time to Buy?

LON:BATS
Read British American Tobacco (LON:BATS) Hits New 12-Month High - What's Next?
BCB Bancorp logo with Finance background

James G. Rizzo Purchases 2,000 Shares of BCB Bancorp, Inc. (NASDAQ:BCBP) Stock

MarketBeat

BCB Bancorp, Inc. (NASDAQ:BCBP - Get Free Report) Director James G. Rizzo purchased 2,000 shares of the firm's stock in a transaction dated Friday, June 13th. The shares were acquired at an average cost of $7.70 per share, with a total value of $15,400.00. Following the completion of the purchase, the director now directly owns 62,708 shares in the company, valued at approximately $482,851.60. This represents a 3.29% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

NASDAQ:BCBP
Read James G. Rizzo Purchases 2,000 Shares of BCB Bancorp, Inc. (NASDAQ:BCBP) Stock
Smith Douglas Homes logo with Finance background

George Ervin Perdue III Acquires 1,400 Shares of Smith Douglas Homes Corp. (NYSE:SDHC) Stock

MarketBeat

Smith Douglas Homes Corp. (NYSE:SDHC - Get Free Report) Director George Ervin Perdue III purchased 1,400 shares of the firm's stock in a transaction that occurred on Friday, June 13th. The stock was acquired at an average price of $18.25 per share, for a total transaction of $25,550.00. Following the completion of the purchase, the director now owns 40,384 shares of the company's stock, valued at approximately $737,008. This represents a 3.59% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

NYSE:SDHC
Read George Ervin Perdue III Acquires 1,400 Shares of Smith Douglas Homes Corp. (NYSE:SDHC) Stock

Trending News

All MarketBeat Instant News Alerts

Smith Douglas Homes logo with Finance background

Insider Buying: Smith Douglas Homes Corp. (NYSE:SDHC) Director Acquires 3,500 Shares of Stock

MarketBeat
NYSE:SDHC
Read Insider Buying: Smith Douglas Homes Corp. (NYSE:SDHC) Director Acquires 3,500 Shares of Stock
Navitas Semiconductor logo with Computer and Technology background

Navitas Semiconductor Co. (NASDAQ:NVTS) CFO Sells $800,000.00 in Stock

MarketBeat
NASDAQ:NVTS
Read Navitas Semiconductor Co. (NASDAQ:NVTS) CFO Sells $800,000.00 in Stock
Rolls-Royce Holdings plc logo with Industrials background

Angela Strank Buys 2,837 Shares of Rolls-Royce Holdings plc (LON:RR) Stock

MarketBeat
LON:RR
Read Angela Strank Buys 2,837 Shares of Rolls-Royce Holdings plc (LON:RR) Stock
Gold Royalty logo with Basic Materials background

HC Wainwright Reaffirms Buy Rating for Gold Royalty (NYSE:GROY)

MarketBeat
NYSE:GROY
Read HC Wainwright Reaffirms Buy Rating for Gold Royalty (NYSE:GROY)
SurgePays logo with Computer and Technology background

SurgePays (NASDAQ:SURG) Price Target Raised to $9.00

MarketBeat
NASDAQ:SURG
Read SurgePays (NASDAQ:SURG) Price Target Raised to $9.00
Duos Technologies Group logo with Business Services background

Ascendiant Capital Markets Issues Positive Forecast for Duos Technologies Group (NASDAQ:DUOT) Stock Price

MarketBeat
NASDAQ:DUOT
Read Ascendiant Capital Markets Issues Positive Forecast for Duos Technologies Group (NASDAQ:DUOT) Stock Price
Coinbase Global logo with Finance background

Coinbase Global (NASDAQ:COIN) Receives Buy Rating from Rosenblatt Securities

MarketBeat
NASDAQ:COIN
Read Coinbase Global (NASDAQ:COIN) Receives Buy Rating from Rosenblatt Securities
Bitdeer Technologies Group logo with Business Services background

Bitdeer Technologies Group (NASDAQ:BTDR) Earns Buy Rating from Rosenblatt Securities

MarketBeat
NASDAQ:BTDR
Read Bitdeer Technologies Group (NASDAQ:BTDR) Earns Buy Rating from Rosenblatt Securities
Canaan logo with Computer and Technology background

Canaan (NASDAQ:CAN) Given "Buy" Rating at Rosenblatt Securities

MarketBeat
NASDAQ:CAN
Read Canaan (NASDAQ:CAN) Given "Buy" Rating at Rosenblatt Securities
IMAX logo with Consumer Discretionary background

IMAX's (IMAX) "Buy" Rating Reiterated at Rosenblatt Securities

MarketBeat
NYSE:IMAX
Read IMAX's (IMAX) "Buy" Rating Reiterated at Rosenblatt Securities
Hinge Health logo with Services background

Needham & Company LLC Initiates Coverage on Hinge Health (NYSE:HNGE)

MarketBeat
NYSE:HNGE
Read Needham & Company LLC Initiates Coverage on Hinge Health (NYSE:HNGE)
Hinge Health logo with Services background

Hinge Health (NYSE:HNGE) Now Covered by Analysts at KeyCorp

MarketBeat
NYSE:HNGE
Read Hinge Health (NYSE:HNGE) Now Covered by Analysts at KeyCorp
Hinge Health logo with Services background

Hinge Health (NYSE:HNGE) Coverage Initiated by Analysts at Canaccord Genuity Group

MarketBeat
NYSE:HNGE
Read Hinge Health (NYSE:HNGE) Coverage Initiated by Analysts at Canaccord Genuity Group
Arcellx logo with Medical background

Arcellx (NASDAQ:ACLX) Receives Buy Rating from HC Wainwright

MarketBeat
NASDAQ:ACLX
Read Arcellx (NASDAQ:ACLX) Receives Buy Rating from HC Wainwright
BioNTech logo with Medical background

BioNTech (NASDAQ:BNTX) Price Target Cut to $138.00 by Analysts at HC Wainwright

MarketBeat
NASDAQ:BNTX
Read BioNTech (NASDAQ:BNTX) Price Target Cut to $138.00 by Analysts at HC Wainwright
Signet Jewelers logo with Retail/Wholesale background

Signet Jewelers (NYSE:SIG) Now Covered by Analysts at Jefferies Financial Group

MarketBeat
NYSE:SIG
Read Signet Jewelers (NYSE:SIG) Now Covered by Analysts at Jefferies Financial Group
Medtronic logo with Medical background

Medtronic (NYSE:MDT) Now Covered by Analysts at Leerink Partners

MarketBeat
NYSE:MDT
Read Medtronic (NYSE:MDT) Now Covered by Analysts at Leerink Partners
Boston Scientific logo with Medical background

Boston Scientific (NYSE:BSX) Earns Outperform Rating from Analysts at Leerink Partners

MarketBeat
NYSE:BSX
Read Boston Scientific (NYSE:BSX) Earns Outperform Rating from Analysts at Leerink Partners
Hinge Health logo with Services background

Hinge Health (NYSE:HNGE) Coverage Initiated at Barclays

MarketBeat
NYSE:HNGE
Read Hinge Health (NYSE:HNGE) Coverage Initiated at Barclays
Intellia Therapeutics logo with Medical background

Intellia Therapeutics' (NTLA) Buy Rating Reaffirmed at HC Wainwright

MarketBeat
NASDAQ:NTLA
Read Intellia Therapeutics' (NTLA) Buy Rating Reaffirmed at HC Wainwright
Janover logo with Financial Services background

Janover (NASDAQ:DFDV) Coverage Initiated at Cantor Fitzgerald

MarketBeat
NASDAQ:DFDV
Read Janover (NASDAQ:DFDV) Coverage Initiated at Cantor Fitzgerald
Sarepta Therapeutics logo with Medical background

Sarepta Therapeutics (NASDAQ:SRPT) Downgraded by BMO Capital Markets to Market Perform

MarketBeat
NASDAQ:SRPT
Read Sarepta Therapeutics (NASDAQ:SRPT) Downgraded by BMO Capital Markets to Market Perform
Sarepta Therapeutics logo with Medical background

Sarepta Therapeutics (NASDAQ:SRPT) Cut to Sell at HC Wainwright

MarketBeat
NASDAQ:SRPT
Read Sarepta Therapeutics (NASDAQ:SRPT) Cut to Sell at HC Wainwright
Sarepta Therapeutics logo with Medical background

Sarepta Therapeutics (NASDAQ:SRPT) Stock Rating Lowered by Piper Sandler

MarketBeat
NASDAQ:SRPT
Read Sarepta Therapeutics (NASDAQ:SRPT) Stock Rating Lowered by Piper Sandler

Featured Articles and Offers

Sector News